Low Incidence Rate of Opportunistic and Viral Infections During Imatinib Treatment in Chronic Myeloid Leukemia Patients in Early and Late Chronic Phase.

BACKGROUND: Imatinib has become first line therapy in chronic myeloid leukemia patients. Little is known about the infective consequences during the treatment with this drug in large series of chronic phase patients. MATERIAL AND METHODS: From January 2001 to September 2006 we treated with imatinib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Breccia, Massimo, Girmenia, Corrado, Latagliata, Roberto, Loglisci, Giuseppina, Santopietro, Michelina, Federico, Vincenzo, Petrucci, Luigi, Serrao, Alessandra, Salaroli, Adriano, Alimena., Giuliana
Formato: Artigo
Idioma:Inglês
Publicado em: Università Cattolica del Sacro Cuore 2011
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3113277/
https://ncbi.nlm.nih.gov/pubmed/21713076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2011.021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados